Merger market - May 12, 2020 - Uvence A Revolutionary Treatment
post-template-default,single,single-post,postid-16604,single-format-standard,bridge-core-2.0.5,ajax_fade,page_not_loaded,,side_area_uncovered_from_content,qode-child-theme-ver-1.0.0,qode-theme-ver-19.2.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Merger market – May 12, 2020

Uvence, a London-based aesthetic skin care company, is looking to raise at least USD 15m in a Series B round to expand its market reach, according to CEO and co-founder Reece Tomlinson.

The company, founded in 2017, offers its proprietary skin treatment process at two London medical centres and expects to expand to 25 UK locations by end-2020, said Tomlinson.

The company offers a skin treatment that involves removing and purifying a patient’s own fat cells and injecting the solution back into the skin surface in the face, neck, hand and breast, a technology that is designed to enhance skin cell regeneration qualities. The skin cell solution is comprised of living fat cells including stem cells and other regenerative “super enriched tissues,” and can be stored cryogenically for up to five years for future treatments, it says.

Read full article

No Comments

Post A Comment